The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | D | Dermatologicals | |
| 2 | D01 | Antifungals for dermatological use | |
| 3 | D01A | Antifungals for topical use | |
| 4 | D01AC | Imidazole and triazole derivatives | |
| 5 | D01AC19 |
| Active Ingredient | Description | |
|---|---|---|
| Efinaconazole |
Efinaconazole is an azole antifungal used for the topical treatment of onychomycosis. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| JUBLIA Solution | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
